Omni Bio Pharmaceutical Inc (OMBP.OB)

OMBP.OB on OTC BB

0.44USD
19 Dec 2014
Price Change (% chg)

$0.05 (+12.82%)
Prev Close
$0.39
Open
$0.36
Day's High
$0.45
Day's Low
$0.36
Volume
67,054
Avg. Vol
25,645
52-wk High
$0.50
52-wk Low
$0.15

OMBP.OB

Chart for OMBP.OB

About

Omni Bio Pharmaceutical, Inc. (Omni Bio) is a development-stage company. The Company is a biopharmaceutical company that was initially formed to explore new methods of use of Alpha-1 antitrypsin (AAT), also referred to as plasma-derived AAT. The Company holds a license to an issued method of use patent for the treatment of... (more)

Overall

Beta: -0.47
Market Cap (Mil.): $17.21
Shares Outstanding (Mil.): 39.11
Dividend: --
Yield (%): --

Financials

  OMBP.OB Industry Sector
P/E (TTM): -- 179.07 38.47
EPS (TTM): -0.08 -- --
ROI: -- -0.72 18.25
ROE: -- -1.88 19.13
Search Stocks

Competitors

  Price Change
Johnson & Johnson (JNJ.N) $105.55 --
Novartis AG (NOVN.VX) CHF93.05 +0.95
Merck & Co., Inc. (MRK.N) $59.58 --
Roche Holding Ltd. (ROG.VX) CHF270.40 -18.30
Sanofi SA (SASY.PA) €75.66 +0.28
Amgen, Inc. (AMGN.OQ) $170.17 +1.69
Gilead Sciences, Inc. (GILD.OQ) $108.45 --

Earnings vs. Estimates

Search Stocks